Fig. 1From: Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysisTimeline of the study design. Subjects without diabetes were followed from the first examination to the second examination for the fasting plasma glucose (FPG) changes [1] Normal fasting glucose (NFG) to NFG, [2] NFG to impaired fasting glucose (IFG), [3] NFG to type 2 diabetes mellitus (T2DM), [4] IFG to NFG, [5] IFG to IFG [6] IFG to T2DM. *Only ARIC and TLGS participants were assessed for cancer mortality outcomes and followed-up for a median of 25.1Â yearsBack to article page